Grantham, Mayo, Van Otterloo & Co (GMO)
ABT icon

Grantham, Mayo, Van Otterloo & Co (GMO)’s Abbott ABT Stock Holding History

Grantham, Mayo, Van Otterloo & Co (GMO)’s Portfolio ABT Stock Details ABT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q3 		– Sell
-173,800
Closed -$6.83M – 507
2016
Q2 		$6.83M Buy
+173,800
New +$6.92M 0.03% 268

Other funds holding ABT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Grantham, Mayo, Van Otterloo & Co (GMO)'s ABT Position: Q1 2026 in Review

Grantham, Mayo, Van Otterloo & Co (GMO) increased its Abbott (ABT) stake by 5.1% in Q1 2026, buying an estimated $48.4M and bringing the position to 8,910,945 shares worth $915M. The position accounts for 2.34% of the portfolio, ranked #13.

Grantham, Mayo, Van Otterloo & Co (GMO) first reported a position in ABT in Q2 2013 and has held it in 52 quarters since. The position peaked at $1.1B in Q3 2025. 3,085 funds tracked by Wall St. Rank hold ABT as of Q1 2026.

  • Grantham, Mayo, Van Otterloo & Co (GMO) held 8,910,945 shares of Abbott worth $915M as of Q1 2026.
  • Grantham, Mayo, Van Otterloo & Co (GMO) bought 428,392 Abbott shares in Q1 2026, an estimated $48.4M.
  • Abbott made up 2.34% of Grantham, Mayo, Van Otterloo & Co (GMO)'s portfolio in Q1 2026, its #13 holding.
  • Grantham, Mayo, Van Otterloo & Co (GMO) first reported a position in Abbott in Q2 2013 and has held it in 52 quarters since.
  • Grantham, Mayo, Van Otterloo & Co (GMO)'s Abbott position peaked at $1.1B in Q3 2025.
  • 3,085 funds tracked by Wall St. Rank held Abbott as of Q1 2026.

Based on Grantham, Mayo, Van Otterloo & Co (GMO)'s 13F filing for Q1 2026, filed 14 May 2026.